| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbf72a41730a0f91311a7952e8d2f16f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cba8a08bfef668b7aa6a6f001f75b287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac58bdfaf1246d6f59a53d542b6ea91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dcf6af40a8b00e1e2cf232b81db2642 |
| publicationDate |
2021-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021201588-A1 |
| titleOfInvention |
Heparin-bile acid oligomer conjugates for anticancer therapy |
| abstract |
The present invention relates to heparin-bile acid oligomer conjugates used in anticancer therapy. Particularly, the present invention provides: a pharmaceutical composition for anticancer or an anticancer adjuvant, containing a compound represented by chemical formula I or a pharmaceutically acceptable salt thereof; and an anticancer combined composition containing the pharmaceutical composition and one or more anticancer agents. A compound represented by chemical formula I or a pharmaceutically acceptable salt thereof of the present invention inhibits cancer-related thrombosis so as to alleviate tumor perfusion, thereby exhibiting excellent anticancer effects when administered alone or in combination with another anticancer agent, and thus can be used as an effective anticancer therapy when administered alone or used in combination with another anticancer therapy. |
| priorityDate |
2020-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |